Copyright
©The Author(s) 2021.
World J Clin Cases. May 6, 2021; 9(13): 2994-3007
Published online May 6, 2021. doi: 10.12998/wjcc.v9.i13.2994
Published online May 6, 2021. doi: 10.12998/wjcc.v9.i13.2994
Table 1 Patient demographics and clinical characteristics in the training and internal validation sets
Training sets | Internal testing sets | |||||
Mild, n = 224 (62.0%) | Severe, n = 38 (10.5%) | P value | Mild, n = 90 (25.8%) | Severe, n = 9 (2.5%) | P value | |
Age (yr) | 48.5 (36.0-59.0) | 64 (57.5-66.0) | 43.0 (34.0-54.8) | 64.0 (62.0-69.0) | ||
≥ 60 yr | 54 (24.1) | 26 (68.4) | 0.000 | 14 (15.6) | 8 (88.9) | 0.000 |
Sex | 0.002 | 0.159 | ||||
Male | 106 (47.3) | 29 (76.3) | 38 (42.2) | 6 (66.7) | ||
Female | 118 (52.7) | 9 (23.7) | 52 (57.8) | 3 (33.3) | ||
BMI > 24 | 57 (25.4) | 11 (28.9) | 0.000 | 22 (24.4) | 4 (44.4) | 0.024 |
BMI > 27 | 21 (9.4) | 14 (36.8) | 5 (5.6) | 2 (22.2) | ||
Onset to hospitalization (> 5 d) | 62 (27.7) | 25 (65.8) | 0.000 | 34 (37.8) | 5 (55.6) | 0.000 |
Symptoms | ||||||
Fever > 37.3°C | 172 (76.8) | 29 (76.3) | 0.000 | 78 (86.7) | 7 (77.8) | 0.005 |
Fever > 39°C | 8 (3.6) | 7 (18.4) | 1 (1.1) | 2 (22.2) | ||
Charlson index > 0 | 72 (32.2) | 33 (86.8) | 0.000 | 39 (43.3) | 8 (88.9) | 0.000 |
P/F | 13 (5.8) | 16 (42.1) | 0.000 | 3 (3.3) | 3 (33.3) | 0.006 |
NLR > 2 | 80 (35.7) | 15 (39.5) | 0.000 | 39 (16.7) | 3 (33.3) | 0.009 |
NLR > 4 | 24 (10.7) | 17 (44.7) | 7 (7.8) | 4 (44.4) | ||
Score ≥ 7 | 31 (13.8) | 35 (92.1) | 0.000 | 13 (13.1) | 9 (100) | 0.000 |
Table 2 Demographic clinical characteristics of external validation sets
Mild, n = 110 (%) | Severe, n = 16 | P value | |
Age (yr) | 49.0 (35.0-57.8) | 70.0 (64.0-78.0) | |
> 60 | 27 (24.6) | 12 (75.0) | 0.000 |
Sex | 0.007 | ||
Male | 51 (46.4) | 13 (81.3) | |
Female | 59 (53.6) | 3 (18.7) | |
BMI > 24 | 30 (27.3) | 8 (50.0) | 0.021 |
> 27 | 15 (13.6) | 4 (25.0) | |
Onset to hospitalization (> 5 d) | 37 (33.6) | 15 (94.0) | 0.000 |
Symptoms | |||
Fever > 37.3°C | 87 (79.1) | 12 (75.0) | 0.025 |
Fever > 39°C | 4 (3.6) | 3 (18.8) | |
Charlson index > 0 | 54 (49.1) | 15 (93.8) | 0.000 |
P/F | 1 (0.9) | 6 (37.5) | 0.000 |
NLR > 2 | 44 (40.0) | 2 (12.5) | 0.000 |
NLR > 4 | 6 (5.5) | 14 (87.5) | |
Score ≥ 7 | 23 (20.9) | 15 (93.8) | 0.000 |
Table 3 Risk factors of severe patients with coronavirus disease 2019
Variable | Univariate analysis | Multivariate analysis | ||
OR | P value | OR | P value | |
Age ≥ 60 yr | 6.821 (3.224-14.431) | 0.000 | - | - |
Sex | 3.587 (1.624-7.924) | 0.002 | - | - |
BMI | 2.701 (1.727-4.224) | 0.000 | 3.939 (1.409-11.015) | 0.009 |
Illness onset at admission | 5.025 (2.418-10.441) | 0.000 | 7.107 (1.449-34.849) | 0.016 |
Smoker | 4.060 (1.912-8.621) | 0.000 | - | - |
Dry cough | 3.395 (1.604-7.184) | - | - | |
Productive sputum | 2.612 (1.284-5.312) | 0.008 | - | - |
Fever | 4.615 (1.948-10.935) | 0.001 | 6.794(1.401-32.951) | 0.017 |
Shortness of breath | 3.312 (1.161-9.448) | 0.025 | - | - |
Fatigue | 3.450 (1.661-7.164) | 0.001 | - | - |
Charlson index | 2.371 (1.813-3.100) | 0.000 | 2.917 (1.279-6.654) | 0.011 |
PaO2/FiO2 | 11.804 (5.028-27.714) | 0.000 | 17.570 (1.117-276.832) | 0.041 |
Platelet count | 0.423 (0.180-0.992) | 0.048 | - | - |
NLR | 3.766 (2.271-6.245) | 0.000 | 3.574 (1.048-12.191) | 0.042 |
D-Dimer | 4.385 (2.102-9.148) | 0.000 | - | - |
ESR | 11.023 (2.583-47.048) | 0.001 | - | - |
hs-CRP | 4.314 (2.359-7.887) | 0.000 | - | - |
AST | 6.332 (2.753-14.563) | 0.000 | - | - |
Cr | 16.258 (3.994-66.188) | 0.000 | - | - |
IL-6 | 2.346 (1.224-4.494) | 0.010 | - | - |
PCT | 3.961 (1.062-14.772) | 0.040 | - | - |
ROX | 0.237 (0.111-0.505) | 0.000 | - | - |
Table 4 The proposed score rules for clinical diagnosis of severe coronavirus disease 2019
Variables | Description | Score |
BMI | ≥ 24 | 1 |
≥ 27 | 2 | |
Time from onset to admission | ≥ 5 d | 2 |
Fever | ≥ 37.3 °C | 2 |
≥ 39 °C | 4 | |
Charlson index | 1 | |
P/F score | < 300 | 6 |
NLR | ≥ 2 | 1 |
≥ 4 | 2 |
Table 5 Comparison of predictive performance between the proposed method and CURB-65
Proposed model | CURB-65 | |
Internal validation | ||
AUROC | 0.941 (0.901-0.981) | 0.704 (0.564-0.863) |
Precision | 0.270 (0.234-0.307) | 1.000 |
Sensitivity | 0.930 (0.896-0.964) | 0.156 (0.085-0.228) |
Specificity | 0.622 (0.602-0.641) | 1.000 |
External validation | ||
AUROC | 0.936 (0.886-0.987) | 0.654 (0.518-0.791) |
Precision | 0.413 (0.261-0.565) | 0.481 (0.254-0.708) |
Sensitivity | 0.927 (0.873-0.980) | 0.292 (0.186-0.399) |
Specificity | 0.804 (0.728-0.880) | 0.954 (0.925-0.983) |
- Citation: Tang M, Yu XX, Huang J, Gao JL, Cen FL, Xiao Q, Fu SZ, Yang Y, Xiong B, Pan YJ, Liu YX, Feng YW, Li JX, Liu Y. Clinical diagnosis of severe COVID-19: A derivation and validation of a prediction rule. World J Clin Cases 2021; 9(13): 2994-3007
- URL: https://www.wjgnet.com/2307-8960/full/v9/i13/2994.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i13.2994